Wegovy Gas and Burping: What the Evidence Says

What the STEP 1 trial data actually recorded about GI side effects

The STEP 1 trial, published in the New England Journal of Medicine, enrolled 1,961 adults with obesity and followed them for 68 weeks on semaglutide 2.4mg or placebo. Gastrointestinal events were the most frequent adverse effects in the semaglutide group, reported by a substantial majority of participants. Nausea topped the list, but burping, flatulence and bloating featured consistently in the safety tables alongside diarrhoea and constipation.

The NHS semaglutide medicines page lists burping and flatulence explicitly as common side effects, meaning they occur in more than one in ten people taking the medicine. That classification is drawn directly from the SmPC and the trial safety data, so these are not anecdotal complaints; they are expected, documented reactions.

Most GI events in the trial were mild to moderate in severity. Rates tended to peak during the escalation phase, when the dose was being increased every four weeks, and settled once participants reached a stable maintenance dose. A smaller proportion of people stopped treatment because of GI intolerance, but the majority stayed in the trial and reported improving tolerability over time. That pattern matches what prescribers observe in clinical practice: the first few weeks are usually the most uncomfortable.

Why semaglutide causes gas: the gastric emptying explanation

Semaglutide works primarily through GLP-1 receptors, which slow the rate at which the stomach empties into the small intestine. That slowing is part of how Wegovy reduces appetite (food stays in the stomach longer, keeping you feeling full) but it also means air swallowed during eating has more time to accumulate before moving on. The result is pressure that exits the way it can: upward as burping, or further along as flatulence.

A question our prescribers hear most weeks is whether burping means the medicine is working too hard or something is going wrong. In most cases, the answer is no. Belching is an almost mechanical consequence of slowed gastric motility, not a sign of damage or a reason to stop treatment without speaking to your prescriber first. If the burping is severe, persistent, or accompanied by pain that radiates to the back, that is different, see the section below on when to seek help.

Fatty foods make things worse. Fat independently slows gastric emptying, so a high-fat meal on top of semaglutide's own effect can compound the gas and bloating considerably. Many people find that cutting back on fried food, full-fat dairy and rich sauces reduces burping noticeably, independent of any other change. Fizzy drinks add gas directly and are worth setting aside, at least during the adjustment period. You can read more about how the broader Wegovy side effect profile fits together, or explore the specific connection between burping and semaglutide in more detail.

Practical steps that reduce gas and burping on Wegovy

None of the following requires stopping treatment or reducing your dose. They are the practical adjustments most likely to make the GI phase more tolerable.

Eat smaller portions, more slowly, and chew thoroughly. Rushed eating traps more air. Splitting three meals into four or five smaller ones across the day means less food sitting in a slowed stomach at once. Many people on Wegovy find their appetite has already dropped enough to make smaller portions natural rather than forced.

Avoid lying down immediately after eating. Remaining upright for at least an hour helps gas move in the right direction rather than building pressure against the lower oesophageal sphincter.

Cut carbonated drinks. This is straightforward, sparkling water, sodas and fizzy mixers all introduce gas that the stomach then needs to expel.

Keep a rough food log for a fortnight. Certain foods produce more gas in some people than others: onions, legumes, cruciferous vegetables and some high-fibre foods are common culprits. Identifying your personal triggers is more useful than cutting broad categories wholesale. For a broader view of how burping and diarrhoea interact on Wegovy, that page covers the gut-motility picture in full.

If burping is consistently disrupting sleep or making eating unpleasant, raise it with your prescriber. Dose timing, speed of escalation, and occasionally the pace of titration can all be reviewed, but those decisions sit with the clinician who knows your case. Curious about the cost of Wegovy through a private pharmacy? That page sets out what a legitimate private prescription typically involves.

When gas and burping warrant medical attention

For the vast majority of people, burping on Wegovy is an inconvenience that follows a predictable pattern as the body adjusts to the medicine. There are circumstances, though, where GI symptoms should prompt a call to your prescriber or, if severe, urgent medical help.

The MHRA highlighted acute pancreatitis in a Drug Safety Update for GLP-1 medicines: the warning sign is severe, persistent abdominal pain that may spread to the back, with or without vomiting. That is categorically different from ordinary burping or bloating. Pancreatitis is uncommon with semaglutide, but when it occurs it is serious, do not wait to see whether it settles on its own. Suspected side effects can be reported to the MHRA at Yellow Card.

Other signs worth reporting promptly: significant vomiting that prevents you keeping fluids down for more than a day, sudden severe abdominal pain, or symptoms of gallbladder trouble (pain in the upper right abdomen, especially after eating). None of these are common, but they sit at the serious end of the GI spectrum and your prescriber needs to know about them. If you have questions about whether burping is an expected side effect of Wegovy, that page addresses the question directly. For general treatment options, starting a free consultation is the first step toward speaking to one of our prescribers.